All Stories

VC firm Kineticos launches biotech to develop fresh approach to antibiotic resistance

Venture capital firm Kineticos Life Sciences has launched a new biotech to take forward a class of antibiotics forged in the labs of Harvard University.

Feb 24, 2025 - 13:23
 0
VC firm Kineticos launches biotech to develop fresh approach to antibiotic resistance
Venture capital firm Kineticos Life Sciences has launched a new biotech to take forward a class of antibiotics forged in the labs of Harvard University.
Read More

Tags:

Previous Article

BMW stalls electric Mini production at Oxford plant due to 'industry uncertainties'

Next Article

Winegrower vandalises vines belonging to CAVB boss

Related Posts

Corbus posts first US data on challenger to Pfizer's ADC Padcev

Corbus posts first US data on challenger to Pfizer's AD...

Feb 17, 2025  0

Novo Nordisk adds pediatric data to bulging bag of evidence on near-approval hemophilia A prospect

Novo Nordisk adds pediatric data to bulging bag of evid...

Feb 9, 2025  0

Chutes & Ladders—Private equity firms take over bluebird's nest

Chutes & Ladders—Private equity firms take over bluebir...

Feb 28, 2025  0